The Biotechnology Industry Organization and Generic Pharmaceutical Association are jointly raising concerns about aspects of a recently introduced House compounding bill that is the subject of bicameral talks, including the measure's volume limit and other sections they say could still allow large-scale copying of FDA-approved drugs.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment